Skip to main content
Erschienen in: Pain and Therapy 2/2024

Open Access 22.02.2024 | LETTER

Letter to the Editor Regarding “The Role of Ultrasound-Guided Multipoint Fascial Plane Block in Elderly Patients Undergoing Combined Thoracoscopic-Laparoscopic Esophagectomy: A Prospective Randomized Study”

verfasst von: Xin-Tao Li, Fu-Shan Xue, Yi Cheng

Erschienen in: Pain and Therapy | Ausgabe 2/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
This comment refers to the article available online at https://​doi.​org/​10.​1007/​s40122-023-00514-0.
Dear Editor,
We read with great interest the recent article by Zhu et al. [1] assessing intraoperative and postoperative benefits of adding ultrasound-guided multipoint fascial plane block to total intravenous anesthesia in 80 elderly patients who underwent the combined thoracoscopic-laparoscopic esophagectomy. They showed that the addition of multipoint fascia pane block significantly decreased the dosages of drugs used for general anesthesia, improved the quality of awakening, and reduced postoperative pain without obvious adverse reactions. In addition to the limitations described by the authors in the Discussion section, however, we noted several issues in the Methods and Results sections of this study which required further clarification.
First, in the Methods section, the authors did not clearly describe whether trocar site infiltration of local anesthetic was performed in all patients. As an important component of the current enhanced recovery after surgery (ERAS) protocols for thoracoscopic or laparoscopic surgery, trocar site infiltration of local anesthetic has been shown to improve postoperative pain control with less opioid consumption and enhance postoperative recovery [2, 3]. We are concerned that an between-group imbalance in this factor would have biased Zhu et al.’s findings of postoperative outcomes.
Second, parecoxib 40 mg was immediately administered as rescue analgesic when postoperative pain visual analog scale (VAS) score was more than 4. In fact, parecoxib only is a weak analgesic and recommended as basis of multimodal postoperative analgesia protocols in the current ERAS practice. A main goal of ERAS programs is to minimize opioid use, but strong analgesics, such as opioid drugs, are often recommended as rescue analgesics for inadequate postoperative pain control [4]. We believe that different results of postoperative analgesia including the time to first rescue analgesic and  the need for rescue analgesic in the two groups would have been obtained if this study’s design included a basic analgesic package (such as paracetamol, nonsteroidal anti-inflammatory drugs, or cyclooxygenase-2-specific inhibitors) and a strong rescue analgesic for inadequate postoperative pain control according to multimodal postoperative analgesia protocols of current ERAS practice. Most important, a VAS score of 3 or less is generally considered as satisfactory postoperative pain control [5]. Thus, the current ERAS protocols recommended that analgesics should be universally titrated to minimize postoperative pain (i.e., a VAS of 3 or less) and achieve patient comfort [2, 3]. Because a trigger point of rescue analgesia with a VAS score of more than 4 was designed in this study, mean rest and dynamic pain VAS scores of controlled patients in the early postoperative period were more than 3, with large standard deviations. This indicates that a significant proportion of controlled patients experienced moderate to severe postoperative pain, especially for dynamic pain. Evidently, this is not ideal for successful use of the current ERAS protocols. Furthermore, such an inefficient control group will undoubtedly bias the findings of postoperative analgesia in favor of the intervention group.
Third, the incidences of chronic pain at 3 months and 6 months after surgery tended to increase in the control patients compared with patients receiving multipoint fascial plane block. In the Methods section, however, the authors did not clearly provide a definition of chronic pain.
Finally, in conclusion at the end of article, the authors stated that the addition of multipoint fascia plane block to total intravenous anesthesia reduced the times required to get out of bed and restore gastrointestinal function. However, we did not find that this study included these important outcomes of the current ERAS protocols. Because these important outcomes are lacking, an important question that this study cannot answer is whether the addition of multipoint fascia plane block to total intravenous anesthesia may really improve the targets of the current ERAS protocols, i.e., fast functional recovery with adequate pain control while minimizing side effects [5].

Acknowledgements

All authors have no financial support and potential conflicts of interest for this work.

Authorship.

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Declarations

Conflict of Interest

Xin-Tao Li, Fu-Shan Xue and Yi Cheng declare that they have no conflict of interest for this work.

Ethical Approval

This article is based on a previously conducted study and does not contain any study with human participants or animals performed by any of the authors.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​.
Literatur
1.
Zurück zum Zitat Zhu C, Fang J, Yang J, et al. The role of ultrasound-guided multipoint fascial plane block in elderly patients undergoing combined thoracoscopic-laparoscopic esophagectomy: a prospective randomized study. Pain Ther. 2023;12(3):841–52.CrossRefPubMedPubMedCentral Zhu C, Fang J, Yang J, et al. The role of ultrasound-guided multipoint fascial plane block in elderly patients undergoing combined thoracoscopic-laparoscopic esophagectomy: a prospective randomized study. Pain Ther. 2023;12(3):841–52.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Rao Z, Zhou H, Pan X, et al. Ropivacaine wound infiltration: a fast-track approach in patients undergoing thoracotomy surgery. J Surg Res. 2017;220:379–84.CrossRefPubMed Rao Z, Zhou H, Pan X, et al. Ropivacaine wound infiltration: a fast-track approach in patients undergoing thoracotomy surgery. J Surg Res. 2017;220:379–84.CrossRefPubMed
4.
Zurück zum Zitat Semenkovich TR, Hudson JL, Subramanian M, Kozower BD. Enhanced recovery after surgery (ERAS) in thoracic surgery. Semin Thorac Cardiovasc Surg. 2018;30(3):342–9.CrossRefPubMed Semenkovich TR, Hudson JL, Subramanian M, Kozower BD. Enhanced recovery after surgery (ERAS) in thoracic surgery. Semin Thorac Cardiovasc Surg. 2018;30(3):342–9.CrossRefPubMed
5.
Zurück zum Zitat McEvoy MD, Raymond BL, Krige A. Opioid-sparing perioperative analgesia within enhanced recovery programs. Anesthesiol Clin. 2022;40(1):35–58.CrossRefPubMed McEvoy MD, Raymond BL, Krige A. Opioid-sparing perioperative analgesia within enhanced recovery programs. Anesthesiol Clin. 2022;40(1):35–58.CrossRefPubMed
Metadaten
Titel
Letter to the Editor Regarding “The Role of Ultrasound-Guided Multipoint Fascial Plane Block in Elderly Patients Undergoing Combined Thoracoscopic-Laparoscopic Esophagectomy: A Prospective Randomized Study”
verfasst von
Xin-Tao Li
Fu-Shan Xue
Yi Cheng
Publikationsdatum
22.02.2024
Verlag
Springer Healthcare
Erschienen in
Pain and Therapy / Ausgabe 2/2024
Print ISSN: 2193-8237
Elektronische ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-024-00582-w

Weitere Artikel der Ausgabe 2/2024

Pain and Therapy 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.